Despite the ubiquity of alicyclic amines, there are very few methods available for the late-stage functionalization of these structures. Late stage functionalization approaches are particularly valuable in the context of drug development, since they enable the rapid synthesis of analogues to optimize pharmacokinetic properties. Transition metal-catalyzed C--H bond functionalization offers a powerful approach for the late stage functionalization of bioactive molecules,^[@R1]-[@R4]^ and recent progress in this field has led to thousands of new synthetic methods for selective C--H functionalization in a variety of molecular contexts^[@R3]-[@R6],[@R8],[@R9]^. However, methods for the C--H functionalization of saturated nitrogen heterocycles remain extremely limited ^[@R5],[@R6]^, and are dominated by functionalization of the highly activated C--H bonds α-to nitrogen^[@R10],[@R11],[@R12],[@R13],[@R14]^ ([Fig. 1B, i](#F1){ref-type="fig"}) or of C--H bonds on exocyclic alkyl groups^[@R15],[@R16]^ ([Fig. 1B, ii](#F1){ref-type="fig"}). In contrast, this report describes our approach for achieving the C--H functionalization of alicyclic amine cores at sites remote from nitrogen ([Fig. 1C](#F1){ref-type="fig"}) via nitrogen-directed transannular C--H activation.

We envisioned that coordination of the nitrogen of an alicyclic amine such as piperidine to palladium could enable selective transannular C--H activation^[@R17],\ [@R18]^ to generate a bicyclo\[2.2.1\]palladacycle (exemplified by **1** in [Fig. 2A](#F2){ref-type="fig"}). However, there are several challenges associated with this approach, including: (1) the low equilibrium population of the required boat conformer, (2) the requirement for cleavage of an unactivated 2° C~sp3~--H bond, and (3) the potential susceptibility of the basic amine towards α-oxidation or N-oxidation. With these considerations in mind, we initially selected 3-azabicyclo\[3.1.0\]hexane **2** as a test substrate ([Fig. 2B](#F2){ref-type="fig"}). We anticipated that the bicyclic core of **2** would prearrange it in a boat-like conformation and that the high s-character of the cyclopropyl C--H bonds should lower the barrier for C--H activation relative to a typical 2° C~sp3~--H site^[@R19]^.

The palladium (Pd)-catalyzed reaction of **2** with 4-iodobiphenyl provided only traces of C--H arylated products under a variety of conditions. However, when a second coordinating group (namely an amide derived from Yu\'s *p*-CF~3~C~6~F~4~ aniline; [Fig. 2C](#F2){ref-type="fig"}, **3**)^[@R20],[@R21],[@R22]^ was appended to nitrogen, the reaction afforded **4a** in modest to excellent yield. Notably, no products derived from C--H functionalization of the methyl groups of the fluoroamide directing group were observed in this reaction. This is in marked contrast to other reported applications of this directing group, where C--H functionalization at β-methyl sites is strongly favored^[@R21],[@R22]^. This highlights the complementarity of our approach of leveraging bidentate coordination of an innate sp^3^-hybridized nitrogen of an alicyclic amine substrate along with the fluoroamide to achieve selectivity (i.e., transannular 2° C~sp3~--H functionalization).

The use of 10 mol % of Pd(OAc)~2~ (Ac = acetate) and 1 equiv of AgOAc (an additive commonly used to promote C--H arylation)^[@R23]^ provided 17% of **4a** ([Fig. 2C](#F2){ref-type="fig"}, entry 1). The modest yield of **4a** under these conditions is due to competing formation of aminal **5**, which is believed to arise from α-oxidation of **3** to the corresponding iminium ion followed by intramolecular trapping with the amide nitrogen. Notably, the Ag additive mediates this transformation, and aminal **5** was obtained in 41% yield in the absence of Pd (entry 4). The role of the Ag carboxylate salt in these transformations is to regenerate the Pd carboxylate catalyst by abstraction of iodide from the Pd center^[@R24],[@R25]^. As such, we hypothesized that the Ag salt could be replaced by a non-oxidizing metal carboxylate. A survey of alkali metal pivalate salts revealed that CsOPiv (Piv = pivalate) delivers the arylated product **4a** while suppressing the formation of aminal **5** ([Fig. 2C](#F2){ref-type="fig"}, entry 8). Under the optimal conditions, **4a** was obtained in 92% yield as a single detectable stereoisomer ([Fig. 2C](#F2){ref-type="fig"}, entry 12). X-ray crystallographic characterization of **4a** confirmed that the aryl group is installed on the concave face of the azabicycle ([Fig. 3A](#F3){ref-type="fig"}).

This transannular C--H arylation reaction proceeds in high yield with aryl iodides bearing electron-donating, electron-neutral, and electron-withdrawing substituents (products **4a-e**, [Fig. 3A](#F3){ref-type="fig"}). Many traditionally sensitive functional groups are compatible with this system, including aryl bromides, unprotected phenols, and aromatic aldehydes (products **4f-h**). Both electron-deficient and electron-rich nitrogen heterocycles can be installed (products **4i** and **4j**). Furthermore, a derivative of the amino acid phenylalanine can be coupled to the bicyclo\[3.1.0\] scaffold (product **4k**). Notably, aryl bromides could also be used as the arylating reagent, albeit with reduced efficiency. For example, the use of phenyl bromide resulted in 14% yield of **4c** (see [Table S8 in the supplementary information](#SD1){ref-type="supplementary-material"} for full details).

The directing group can be removed in high yield via reductive cleavage with SmI~2~. Overall, a 52% overall yield is obtained for the three relevant steps converting **2** to **6** (81% for installation of the directing group, 80% for C--H arylation with 4-iodobiphenyl, and 80% for removal of the directing group; [Fig. 3B](#F3){ref-type="fig"}).

A particularly attractive application of this method is in the late-stage derivatization of bioactive molecules. Selective C--H functionalization reactions on complex molecular scaffolds provide valuable opportunities for streamlining analog generation and thereby accelerating structure activity relationship studies^[@R5],[@R6]^. The bicyclo\[3.1.0\] scaffold appears in numerous pharmaceutical candidates, including the serotonin-norepinephrine-dopamine reuptake inhibitor amitifadine (**7**)^[@R26],[@R27]^. As shown in [Fig. 3C](#F3){ref-type="fig"}, appending our directing group to **7** enables transannular C--H arylation to deliver the novel amitifadine derivatives **9a-d** ([Fig. 3C](#F3){ref-type="fig"}).

We next sought to expand this reaction from model substrate **3** to piperidine **10** ([Fig. 4A](#F4){ref-type="fig"}). A thermodynamically unfavorable chair-boat isomerization of the piperidine ring in **10** is required prior to C--H activation ([Fig. 2A](#F2){ref-type="fig"}) and is expected to add at least 6 kcal/mol to the activation barrier relative to substrate **3**^[@R28]^. Under the conditions optimized for **3**, the piperidine substrate **10** afforded only 12% yield of the C--H arylation product **11a**. However, increasing the temperature and changing the solvent led to a significantly improved 44% yield of **11a** ([Fig. 4A](#F4){ref-type="fig"}). Aminals derived from starting material **10** and product **11a** were formed as side products of this reaction (see [Fig. S2 in the supplementary information](#SD1){ref-type="supplementary-material"} for full details), but the reaction mixture could be cleanly converged to a mixture of starting material **10** and product **11a** via treatment with NaBH~4~. Using this work-up procedure, product **11a** was isolated in 55% yield ([Fig. 4A](#F4){ref-type="fig"}). Analogous conditions enabled the transannular C--H arylation of a variety of alicyclic amine derivatives, affording products of mono- and/or diarylation (**11b-i**; [Fig. 4a](#F4){ref-type="fig"}). The structures of **11b-i** were established via a combination of NMR spectroscopy and X-ray crystallography.

While the yields of **11b-i** are moderate in some cases, the de novo synthesis of many of these products would be challenging using traditional synthetic routes. The utility of this transformation is showcased in the late stage C--H arylation of Pfizer\'s smoking cessation drug varenicline (Chantix^®^, **12**, [Fig. 4B](#F4){ref-type="fig"}). The fluoroamide group was appended to **12** to afford **13** in 81% yield. Under our standard C--H arylation conditions, **13** underwent transannular C--H arylation with a variety of aryl iodides to afford **14a-e**. The structure of **14a** was assigned by X-ray crystallography ([Fig. 4B](#F4){ref-type="fig"}), which confirms that the aryl group is installed in an axial orientation. This latter point is particularly noteworthy because the synthesis of this stereoisomer would be challenging using other synthetic approaches^[@R29]^. The C--H arylation of **13** with 4-iodo-*o*-xylene was conducted on scales ranging from 77 mg to 2.5 g of substrate, with nearly identical yields of **14e** (43% and 38% isolated yield, respectively). Based on the established synthesis of varenicline, an independent synthesis of these analogues by more traditional methods would require parallel multistep sequences^[@R30]^. In a similar fashion, our method proved effective for the late-stage C--H functionalization of the natural product cytisine (**15**, a nicotine addiction treatment), converting **16** to **17** in 25% yield. Again, the aryl group is selectively installed at the axial position in this transformation.

In conclusion, this report discloses the transannular C--H arylation of a variety of alicyclic amines. The reaction exhibits high functional group tolerance, and enables the synthesis of novel amino acid derivatives (**4k**) as well as previously unprecedented analogues of the pharmaceutical candidate amitifadine (**9a-d**), the top-selling drug varenicline (**14a-e**), and the natural product cytisine (**17**). We anticipate that a similar approach will ultimately prove broadly useful for the remote C--H functionalization of diverse cyclic and acyclic secondary amine scaffolds.
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![Relevance of alicyclic amines and strategies for their late stage functionalization\
**a**, Representative pharmaceutical agents containing alicyclic amines. **b**, Previous synthetic approaches for the late-stage functionalization of alicyclic amines. R, R^1^, generic substituent; FG, new functional group. **c,** Proposed approach for late stage transannular C--H functionalization of alicyclic amines.](nihms-747007-f0001){#F1}

![Design and realization of transannular C--H activation of alicyclic amines\
**a**, Conceptual approach to transannular C-H arylation of via a bicyclo\[2.2.1\]metallacycle intermediate. \[Pd\], Pd complex. **b**, Evolution of model substrate **2** to **3**. C~7~F~7~, 4-(CF~3~)C~6~F~4~. **c**, Reaction optimization using 4-iodobiphenyl (Aryl-I). *t*-AmylOH, 2-methyl-2-butanol; nd, not detected. All yields determined by gas chromatography (GC). See [supplementary information](#SD1){ref-type="supplementary-material"} for full details.](nihms-747007-f0002){#F2}

![Transannular C--H arylation of 3-azabicyclo\[3.1.0\]hexane core\
**a**, Scope of C--H arylation with respect to the aryl iodide. **b**, Relevant steps in overall transformation: installation of directing group, C--H arylation and SmI~2~-mediated removal of directing group (Aryl = biphenyl). PivCl, pivaloyl chloride; TEA, triethylamine. **c**, C--H arylation applied to amitifiadine. All yields are reported for pure isolated material. †, Reaction was conducted using 20 equiv of PhBr; yield determined by GC. ‡, Reaction was conducted under modified conditions. See [supplementary information](#SD1){ref-type="supplementary-material"} for full details.](nihms-747007-f0003){#F3}

![Transannular C--H arylation of alicyclic amines\
**a**, Scope of the C--H arylation reaction with respect to the amine. **b**, Application of this reaction to the derivatization of varenicline. **c**, Application of this reaction to the derivatization of cytisine. Yields are reported for pure isolated products. †, Reaction was conducted under modified conditions. See [supplementary information](#SD1){ref-type="supplementary-material"} for full details.](nihms-747007-f0004){#F4}
